Literature DB >> 30917200

Beneficiary, Caregiver, and Case Manager Perspectives on the Medication Therapy Management Program Standardized Format.

Kriti Sharma, Catherine E Cooke, Amy Kruger Howard, Rebecca Chater, Nicole J Brandt.   

Abstract

Plan sponsors of Medicare Part D must provide beneficiaries who receive a comprehensive medication review (CMR) with a written summary using the Medicare Part D Medication Therapy Management Standardized Format (SF). The SF is a means to advance consistency in the CMR program by providing a template of expected content. However, barriers remain with beneficiary use and integration into existing electronic health records. The current study assessed Medicare beneficiary, caregiver, and case manager perceptions of the SF through five focus group interviews with a total of 23 participants. Qualitative analysis found that beneficiaries and case managers preferred a consolidated SF document to share and update their entire health care team. Beneficiaries suggested adding information to the SF on dosage, timing, drug interactions, cost, and less expensive alternatives. Identifying elements of the SF that are perceived as useful to beneficiaries will allow for a more streamlined SF that may enhance interoperability among the health care team. [Journal of Gerontological Nursing, 45(4), 7-13.]. Copyright 2019, SLACK Incorporated.

Entities:  

Mesh:

Year:  2019        PMID: 30917200     DOI: 10.3928/00989134-20190311-01

Source DB:  PubMed          Journal:  J Gerontol Nurs        ISSN: 0098-9134            Impact factor:   1.254


  3 in total

1.  Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.

Authors:  Xiaobei Dong; Chi Chun Steve Tsang; Shirong Zhao; Jim Y Wan; Ya-Chen Tina Shih; Marie A Chisholm-Burns; Samuel Dagogo-Jack; William C Cushman; Lisa E Hines; Junling Wang
Journal:  Am Health Drug Benefits       Date:  2021-09

Review 2.  Evolution of the Medicare Part D Medication Therapy Management Program from Inception in 2006 to the Present.

Authors:  Cori Gray; Catherine E Cooke; Nicole Brandt
Journal:  Am Health Drug Benefits       Date:  2019-09

3.  Effects of the Medicare Part D comprehensive medication review on medication adherence among patients with Alzheimer's disease.

Authors:  Xiaobei Dong; Chi Chun Steve Tsang; Shirong Zhao; Jamie A Browning; Jim Y Wan; Marie A Chisholm-Burns; Christopher K Finch; Jack W Tsao; Lisa E Hines; Junling Wang
Journal:  Curr Med Res Opin       Date:  2021-06-24       Impact factor: 2.705

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.